R. J. NAYLOR
About
In The Last Decade
R. J. NAYLOR
21 papers receiving 397 citations
Peers
Comparison fields: 5 of 64
- Cellular and Molecular Neuroscience 164
- Surgery 141
- Molecular Biology 102
- Pharmacology 54
- Cognitive Neuroscience 52
Countries citing papers authored by R. J. NAYLOR
This map shows the geographic impact of R. J. NAYLOR's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. J. NAYLOR with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. J. NAYLOR more than expected).
Fields of papers citing papers by R. J. NAYLOR
This network shows the impact of papers produced by R. J. NAYLOR. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. J. NAYLOR. The network helps show where R. J. NAYLOR may publish in the future.
Co-authorship network of co-authors of R. J. NAYLOR
This figure shows the co-authorship network connecting the top 25 collaborators of R. J. NAYLOR. A scholar is included among the top collaborators of R. J. NAYLOR based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. J. NAYLOR. R. J. NAYLOR is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 76 | |
| 3 | 17 | |
| 4 | The effects of 5-HT3 receptor antagonists in models of dependency and withdrawal. | 6 |
| 5 | 43 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 34 | |
| 9 | 10 | |
| 10 | 79 | |
| 11 | 4 | |
| 12 | A demonstration of the ability of apomorphine to act on dopamine receptors on nerve terminals in the nucleus accumbens to reduce locomotor hyperactivity [proceedings]. | 1 |
| 13 | 61 | |
| 14 | The relationship between cholinergic and dopaminergic mechanisms in the nucleus accumbens for the control of locomotor activity [proceedings]. | 5 |
| 15 | 5-HT antagonists inhibit neuroleptic and morphine antagonism of the hyperactivity induced by DA from the nucleus accumbens [proceedings]. | 1 |
| 16 | 4 | |
| 17 | 21 | |
| 18 | Biphasic changes in motor behaviour following morphine injection into the nucleus accumbens [proceedings]. | 4 |
| 19 | 23 | |
| 20 | The distribution of haloperidol in rat brain. | 17 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.